Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
7.99
-0.15 (-1.84%)
Sep 11, 2026, 3:04 PM CST

SHE:300009 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
281.51250.2299.18260.23324.59322.56
Short-Term Investments
42.32141.07----
Trading Asset Securities
1,1081,1921,1451,196842.91805.43
Cash & Short-Term Investments
1,4321,5831,4441,4561,1671,128
Cash Growth
17.81%9.65%-0.82%24.70%3.50%26.10%
Accounts Receivable
441.03495.56492.35597.44476.3543.89
Other Receivables
54.2435.1630.54911.2546.96
Receivables
495.27530.73522.9606.44487.55590.85
Inventory
284.75252.75297.3235.22210.48181.25
Other Current Assets
29.728.3611.0328.0345.0221.53
Total Current Assets
2,2422,3952,2752,3251,9111,922
Property, Plant & Equipment
1,6121,6251,5841,4341,176881.34
Long-Term Investments
497.92789.28515.54404.38347.89188.09
Goodwill
66.5666.5666.5666.5657.657.6
Other Intangible Assets
378.38393.66412.32450.36275.64126.22
Long-Term Deferred Tax Assets
85.1561.541.829.5341.851.22
Long-Term Deferred Charges
217204.8223.28223.8413.28386.18
Other Long-Term Assets
27.3812.1517.1517.134.4156.81
Total Assets
5,1265,5485,1354,9514,2573,669

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
184.72252.28215.02211.7151.01141.11
Accrued Expenses
206.69255.35238.6328.25240.6306.76
Short-Term Debt
71-5-3-
Current Portion of Leases
7.17.6610.718.816.083.3
Current Income Taxes Payable
34.4156.3958.2243.9146.8893.12
Current Unearned Revenue
12.638.0919.3424.4327.9619.51
Other Current Liabilities
40.2459.93120.69229.98200.2762.99
Total Current Liabilities
556.8639.7667.59847.08675.8626.79
Long-Term Leases
20.4925.2938.2547.8224.0623.74
Long-Term Unearned Revenue
127.44123.43121.53113.52114.16107.18
Long-Term Deferred Tax Liabilities
7.2520.578.0510.0141.147.81
Other Long-Term Liabilities
2.472.31----
Total Liabilities
714.45811.3835.411,018855.17765.52

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
1,6711,6731,6731,6771,6731,638
Additional Paid-In Capital
455.12459.5508.66519.82405.73186.87
Retained Earnings
2,2912,3762,0581,7671,337961.26
Treasury Stock
-2.14-14.55-114.57-226.22-207.41-
Comprehensive Income & Other
-155.564.76----
Total Common Equity
4,2604,5584,1243,7373,2092,787
Minority Interest
152.07178.34175.63194.93193.09116.97
Shareholders' Equity
4,4124,7364,3003,9323,4022,904
Total Liabilities & Equity
5,1265,5485,1354,9514,2573,669

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
98.632.9653.9656.6333.1427.04
Net Cash (Debt)
1,3331,5501,3901,3991,1341,101
Net Cash Growth
14.19%11.54%-0.66%23.35%3.03%25.04%
Net Cash Per Share
0.800.930.830.840.690.69
Filing Date Shares Outstanding
1,6471,6661,6781,6611,5891,638
Total Common Shares Outstanding
1,6471,6661,6781,6611,5891,638
Working Capital
1,6851,7551,6081,4781,2351,295
Book Value Per Share
2.592.742.462.252.021.70
Tangible Book Value
3,8154,0983,6453,2202,8752,603
Tangible Book Value Per Share
2.322.462.171.941.811.59
Buildings
848.3767.14545.04583.06564.87469.79
Machinery
856.69809.14760.51624.66562.37528.17
Construction In Progress
529.79620.77799.75672.51445.68228.75